Rituximab for acute demyelinating myelopathy after allogeneic hematopoietic stem cell transplantation: a case report
2020
ABSTRACTAcute demyelinating myelopathy after allogeneic hematopoietic stem cell transplantation (HSCT) is rare, and the exact pathogenesis remains unclear. Here, we report the case of a 20-year-old...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
1
Citations
NaN
KQI